Does CoQ10 help migraine frequency? (Grade B evidence)
For migraine frequency, CoQ10 carries Grade B evidence: probably helps, moderate certainty, especially in adults with episodic migraine, prophylaxis; effect size may shrink with better trials. Dose range commonly 300 mg/day in the trials.
Exact question reviewed
- Population
- adults with episodic migraine, prophylaxis
- Intervention
- CoQ10 · commonly 300 mg/day in the trials
- Comparator
- not reported
- Outcome
- migraine frequency
- Time horizon
- not reported
Bottom line. For migraine frequency, CoQ10 carries Grade B evidence: probably helps, moderate certainty, especially in adults with episodic migraine, prophylaxis; effect size may shrink with better trials. Dose range commonly 300 mg/day in the trials. [1 RCT]
- Direction
- benefit
- Magnitude
- Meta-analysis of RCTs: CoQ10 supplementation reduced migraine attack frequency (and, in some trials, duration) versus placebo; effect on migraine severity was less consistent. Trials are relatively small, so certainty is moderate rather than high.
- Grade
- B
- Certainty
- moderate
- Clinical meaning
- small but potentially useful
- Who it applies to
- adults with episodic migraine, prophylaxis
- Dose / form studied
- commonly 300 mg/day in the trials
- Safety
- not assessed
- The one limitation
- Claim-specific limitation details are not available in this public record.
Reviewed · Evidence last changed · Claim clm_ec_b4-coq10-migraine v0
Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.
Who it works for
Best-studied in adults with episodic migraine, prophylaxis. Recorded studied dose: commonly 300 mg/day in the trials.
Evidence
| Study | Design | Role | Cite |
|---|---|---|---|
| Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis. | peer-reviewed | supports | PMID:33402403 |
Why this grade
Reasoning trace
The current record stores Grade B at moderate certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.
Audit and version
- Claim ID
- ec_b4-coq10-migraine
- Claim version
- not reported
- Governance
- legacy, not verified
- Last evidence search
- not reported
- Last editorial review
- 2026-07-16T15:18:54.262Z
Dose & form
Studied intake: commonly 300 mg/day in the trials.
How it stacks up for migraine frequency
- CoQ10 vs Magnesium for migraine frequency — Magnesium Grade C
- CoQ10 vs Melatonin for migraine frequency — Melatonin Grade C
- CoQ10 vs Vitamin D for migraine frequency — Vitamin D Grade B
- All interventions graded for migraine frequency →
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 12 months (Grade A/B) — next review by . Methodology v1.
Re-review cadence: every 12 months (Grade A/B) · next scheduled by · methodology v1.
Frequently asked
How long does CoQ10 take to work for migraine frequency?
Trials of CoQ10 for migraine frequency typically report effects within 2–4 weeks, though individual response varies. Studies rarely find benefit inside 1 week for chronic outcomes.
What dose was used in studies of CoQ10 for migraine frequency?
Studied doses for CoQ10 in migraine frequency trials cluster around commonly 300 mg/day in the trials. See the dose block for the specific range and how it varies by form.
Does CoQ10 work for migraine frequency if I'm not deficient?
The effect concentrates in adults with episodic migraine, prophylaxis. If your baseline is normal, expect a smaller effect than the trial averages.
CoQ10 or the next-best alternative for migraine frequency?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- Meta-analysis of RCTs: CoQ10 supplementation reduced migraine attack frequency (and, in some trials, duration) versus placebo; effect on migraine severity was less consistent. Trials are relatively small, so certainty is moderate rather than high.
- Substrate's interpretation
- The current reviewed record assigns Grade B at moderate certainty. A domain-by-domain rationale is shown only when recorded.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Does CoQ10 help migraine frequency? (Grade B). https://evidencebased.info/interventions/coq10/migraine. Updated 2026-07-16.
BibTeX
@misc{substrate_entionscoq10migraine,
author = {Substrate editorial},
title = {Does CoQ10 help migraine frequency?},
year = {2026},
url = {https://evidencebased.info/interventions/coq10/migraine},
note = {Grade B, evidencebased.info}
}Found something wrong on this page? Report an error →